Literature DB >> 12425455

Camptothecin delivery methods.

A Hatefi1, B Amsden.   

Abstract

Camptothecin has shown significant antitumor activity to lung, ovarian, breast, pancreas, and stomach cancers. Camptothecin, however, like a number of other potent anticancer agents such as paclitaxel, is extremely water insoluble. Furthermore, pharmacology studies have determined that prolonged schedules of administration given continuously are required. Thus, this insolubility has restricted its clinical application. For these reasons, a number of water-soluble analogs have been synthesized and a number of different formulation approaches have been investigated. In this review, we examine each of these approaches and discuss their advantages and limitations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425455     DOI: 10.1023/a:1020427227285

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  60 in total

1.  Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells.

Authors:  A K Larsen; C Gilbert; G Chyzak; S Y Plisov; I Naguibneva; O Lavergne; L Lesueur-Ginot; D C Bigg
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

2.  9-Nitrocamptothecin liposome aerosol treatment of human cancer subcutaneous xenografts and pulmonary cancer metastases in mice.

Authors:  V Knight; E S Kleinerman; J C Waldrep; B C Giovanella; B E Gilbert; N V Koshkina
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

3.  Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.

Authors:  J W Singer; R Bhatt; J Tulinsky; K R Buhler; E Heasley; P Klein; P de Vries
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

4.  Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT).

Authors:  Y L Leu; S R Roffler; J W Chern
Journal:  J Med Chem       Date:  1999-09-09       Impact factor: 7.446

5.  Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).

Authors:  M R Mattern; G A Hofmann; F L McCabe; R K Johnson
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

Review 6.  Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.

Authors:  M E Wall; M C Wani
Journal:  Cancer Res       Date:  1995-02-15       Impact factor: 12.701

7.  Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.

Authors:  C D Conover; R B Greenwald; A Pendri; C W Gilbert; K L Shum
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

8.  Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.

Authors:  H Takahashi; M Matsuda; A Kojima; T Sata; T Andoh; T Kurata; K Nagashima; W W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

9.  Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Authors:  E K Rowinsky; L B Grochow; C B Hendricks; D S Ettinger; A A Forastiere; L A Hurowitz; W P McGuire; S E Sartorius; B G Lubejko; S H Kaufmann
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

10.  Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

Authors:  Z Mi; T G Burke
Journal:  Biochemistry       Date:  1994-08-30       Impact factor: 3.162

View more
  26 in total

Review 1.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

2.  Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents.

Authors:  Xiao-Bo Zhao; Dan Wu; Mei-Juan Wang; Masuo Goto; Susan L Morris-Natschke; Ying-Qian Liu; Xiao-Bing Wu; Zi-Long Song; Gao-Xiang Zhu; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

3.  Layer-by-layer nanoencapsulation of camptothecin with improved activity.

Authors:  Gaurav Parekh; Pravin Pattekari; Chaitanya Joshi; Tatsiana Shutava; Mark DeCoster; Tatyana Levchenko; Vladimir Torchilin; Yuri Lvov
Journal:  Int J Pharm       Date:  2014-02-06       Impact factor: 5.875

4.  High-Capacity Drug Carriers from Common Polymer Amphiphiles.

Authors:  Zhun Zhou; Oliver Munyaradzi; Xin Xia; Da'Sean Green; Dennis Bong
Journal:  Biomacromolecules       Date:  2016-08-23       Impact factor: 6.988

5.  Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes.

Authors:  Tatsiana G Shutava; Pravin P Pattekari; Kirill A Arapov; Vladimir P Torchilin; Yuri M Lvov
Journal:  Soft Matter       Date:  2012-06-25       Impact factor: 3.679

6.  Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.

Authors:  L Mu; T A Elbayoumi; V P Torchilin
Journal:  Int J Pharm       Date:  2005-10-19       Impact factor: 5.875

Review 7.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

8.  Design, synthesis, cytotoxic activity and molecular docking studies of new 20(S)-sulfonylamidine camptothecin derivatives.

Authors:  Zi-Long Song; Mei-Juan Wang; Lanlan Li; Dan Wu; Yu-Han Wang; Li-Ting Yan; Susan L Morris-Natschke; Ying-Qian Liu; Yong-Long Zhao; Chih-Ya Wang; Huanxiang Liu; Masuo Goto; Heng Liu; Gao-Xiang Zhu; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2016-03-03       Impact factor: 6.514

9.  Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.

Authors:  Jie Liu; Zhaozhong Jiang; Shengmin Zhang; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

10.  Permeation enhancer-containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery.

Authors:  Tsong-Long Hwang; Chia-Lang Fang; Chao-Huang Chen; Jia-You Fang
Journal:  Pharm Res       Date:  2009-08-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.